India gets around 68% of its raw materials — known as active pharmaceutical ingredients (APIs) — from China. Any disruption in that supply chain can create a major problem, especially during a pandemic.
The coronavirus exposed US reliance on India for generic drugs. That supply chain all hinges on China
More Stories
How to land a good work-from-home job
Pfizer’s COVID-19 vaccine has begun rolling out of its Michigan plant in a truck convoy
Iran Sets Out Ambitions to Hike Oil Production Next Year